Back to list

An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study

Philip Home, Nabil El Naggar, Mohammed Khamseh, Guillermo Gonzalez-Galvez, Chunduo Shen, Praful Chakkarwar and Wenying Yang

Diabetes Research and Clinical Practice, Issue 3, Volume 94, pages 352 - 363

Received 20 September 2011, Revised 10 October 2011, Accepted 13 October 2011, Published online Nov-2011


Article view:

Authors

Philip Home a lowast , Nabil El Naggar b, Mohammed Khamseh c, Guillermo Gonzalez-Galvez d, Chunduo Shen e, Praful Chakkarwar e and Wenying Yang f

Footnotes

a Institute of Cellular Medicine – Diabetes, Newcastle University, Newcastle upon Tyne, UK

b Internal Medicine, Hai Aljamea Hospital, Jeddah, Saudi Arabia

c Endocrine Research Center (Firouzgar), Institute of Endocrinology & Metabolism, Tehran University of Medical Sciences, Tehran, Iran

d Instituto Jalisciense de Investigacion en Diabetes y Obesidad, Guadalajara, Mexico

e Novo Nordisk International Operations A/S, Zürich, Switzerland

f China-Japan Friendship Hospital, Beijing, China

lowast Corresponding author at: Institute of Cellular Medicine – Diabetes, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. Tel.: +44 191 222 7154; fax: +44 191 222 0723.

This study was funded by Novo Nordisk.

☆☆ Clinical trial registration: Clinicaltrials.gov, NCT00869908.


Back to list